ECFS Patient Registry Variables Conformity Survey

Thank you for sending your data to the ECFSPR.

To identify any differences in the variables definitions/coding between your national database and the ECFSPR we kindly ask you to fill in this questionnaire. The information will help us in the data analyses, and differences will be highlighted in the annual data report as appropriate. Your help and collaboration in this survey is greatly appreciated.

NB You do not need to login to submit this information.
 

Introductory Information
1. DEMOGRAPHIC
1.1 Year of Birth
1.2. Month of birth
1.3. Day of birth
1.4 Gender
1.5 Status of patient on 31st December of the year of follow-up
1.6 Year of Death
1.7 Month of Death
1.8 Day of Death
1.9 Cause of Death
2. DIAGNOSIS
2.1 Diagnosis confirmed according to the criteria for including patients in the ECFSPR
2.2 Age at diagnosis
2.3 Neonatal screening
2.4 Meconium Ileus
2.5 First mutation
2.6 Second mutation
2.7 Type of sweat test
2.8 Electrolytes
2.9 Sweat test value
2.10 Nasal Potential Difference - NPD
2.11 CF-typical NPD
2.12 Date of NPD Year
2.13 Date of NPD Month
2.14 Date of NPD Day
2.15 Intestinal Current Measurement
2.16 CF-typical ICM
2.17 Date of ICM Year
2.18 Date of ICM Month
2.19 Date of ICM Day
3. THERAPY
3.1 Inhaled continuous (>3 months) hypertonic NaCl during the year of follow-up
3.2 Inhaled continuous (>3 months) Mannitol during the year of follow-up
3.3 Inhaled continuous (>3 months) antibiotic during the year of follow-up
3.4 Inhaled continuous (>3 months) bronchodilators during the year of follow-up
3.5 In oxygen therapy the year of follow-up
3.6 Continuous (>3 months) NIPPV during the year of follow-up
3.7 Use of rhDNase during the year of follow-up
3.8 Continuous (>3 months) inhaled steroids during the year of follow-up
3.9 Continuous (>3 months) oral steroids during the year of follow-up
3.10 Use of continuous (>3 months) Azithromicin (or other macrolide) during the year of follow-up
3.11 Use of ursodeoxycholic acid during the year of follow-up
3.12 Use of pancreatic enzymes during the year of follow-up
3.13 Continuous (>3 months) Proton Pump Inhibitors during the year of follow-up
3.14 Ivacaftor during the year of follow-up
3.15 Start Year of Ivacaftor Treatment
3.16 Start Month of Ivacaftor Treatment
3.17 Start Day of Ivacaftor Treatment
3.18 Stop Year of Ivacaftor Treatment
3.19 Stop Month of Ivacaftor Treatment
3.20 Stop Day of Ivacaftor Treatment
3.21 Lumacaftor / Ivacaftor during the year of follow-up
3.22 Start Year of Lumacaftor / Ivacaftor Treatment
3.23 Start Month of Lumacaftor / Ivacaftor Treatment
3.24 Start Day of Lumacaftor / Ivacaftor Treatment
3.25 Stop Year of Lumacaftor / Ivacaftor Treatment
3.26 Stop Month of Lumacaftor / Ivacaftor Treatment
3.27 Stop Day of Lumacaftor / Ivacaftor Treatment
3.28 Tezacaftor / Ivacaftor during the year of follow-up
3.29 Start Year of Tezacaftor / Ivacaftor Treatment
3.30 Start Month of Tezacaftor / Ivacaftor Treatment
3.31 Start Day of Tezacaftor / Ivacaftor Treatment
3.32 Stop Year of Tezacaftor / Ivacaftor Treatment
3.33 Stop Month of Tezacaftor / Ivacaftor Treatment
3.34 Stop Day of Tezacaftor / Ivacaftor Treatment
3.35 Elexacaftor / Tezacaftor / Ivacaftor during the year of follow-up
3.36 Start Year of Elexacaftor / Tezacaftor / Ivacaftor Treatment
3.37 Start Month of Elexacaftor / Tezacaftor / Ivacaftor Treatment
3.38 Start Day of Elexacaftor / Tezacaftor / Ivacaftor Treatment
3.39 Stop Year of Elexacaftor / Tezacaftor / Ivacaftor Treatment
3.40 Stop Month of Elexacaftor / Tezacaftor / Ivacaftor Treatment
3.41 Stop Day of Elexacaftor / Tezacaftor / Ivacaftor Treatment
3.42 Other CFTR Modulator during the year of follow-up
3.43 Start Year of Other CFTR Modulator Treatment
3.44 Start Month of Other CFTR Modulator Treatment
3.45 Start Day of Other CFTR Modulator Treatment
3.46 Stop Year of Other CFTR Modulator Treatment
3.47 Stop Month of Other CFTR Modulator Treatment
3.48 Stop Day of Other CFTR Modulator Treatment
4. LUNG FUNCTION AND NUTRITION
4.1 Weight measured at date of FEV1 (of best FEV1% of predicted) or, if no lung function test, last weight of the year of follow-up
4.2 Height measured at date of FEV1 (of best FEV1% of predicted) or, if no lung function test, last height of the year of follow-up
4.3 Month of FEV1 measurement
4.4 Day of FEV1 measurement
4.5 Value of FEV1 of best FEV1% of predicted during the year of follow-up
4.6 Value of FVC of the reported FEV1 of highest FEV1% of predicted during the year of follow-up
4.7 Lowest Lung Clearance Index 2,5% during the year of follow-up
4.8 Date of lowest LCI 2,5% this year - month
4.9 Date of lowest LCI 2,5% this year - day
4.10 Device used for lowest LCI 2.5%
5. MICROBIOLOGY
5.1 Chronic Pseudomonas aeruginosa
5.2 Chronic Staphylococcus aureus
5.3 Chronic Burkholderia cepacia
5.4 Haemophilus influenzae this year
5.5 Nontuberculous mycobacteria during the year of follow-up
5.6 Stenotrophomonas maltophilia during the year of follow-up
5.7 Achromobacter spp (species) this year
5.8 Methicillin-resistant Staphylococcus aureus - MRSA - this year
5.9 Total days on intravenous (IV) antibiotics (for CF-related reasons), at home + in hospital, this year
5.10 Total days on intravenous (IV) antibiotics (for CF-related reasons), in hospital only, this year
5.11 Total days in hospital this year, for any reason, not only CF-related, excluding routine checkup days
6. COMPLICATIONS
6.1 Allergic broncho-pulmonary aspergillosis (ABPA) during the year of follow-up
6.2 Distal intestinal obstruction syndrome - DIOS - this year
6.3 Salt Loss Syndrome this year
6.4 Diabetes and type of treatment during the year of follow-up
6.5 Pneumothorax requiring chest drain during the year of follow-up
6.6 Liver disease during the year of follow-up
6.7 Hemoptysis - major over 240 ml - during the year of follow-up
6.8 Occurrence of malignancy during the year of follow-up
6.9 Pancreatic status: faecal elastase
6.10 Pancreatic status: faecal fat
7. TRANSPLANTS
7.1 Last liver transplant
7.2 Year of last liver transplant
7.3 Last lung transplant
7.4 Year of last lung transplant
7.5 Last kidney transplant
7.6 Year of last kidney transplant
7.7 Last other transplant
7.8 Year of last other transplant
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.